Insufficient scRNA-seq data for expression of RASD2 at single-cell level.
Insufficient scRNA-seq data for expression of RASD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 2681.44 | 242 / 245 | 98% | 19.92 | 492 / 502 |
brain | 93% | 7082.35 | 2470 / 2642 | 85% | 12.28 | 597 / 705 |
intestine | 94% | 2931.13 | 910 / 966 | 75% | 7.53 | 394 / 527 |
esophagus | 63% | 3477.72 | 906 / 1445 | 77% | 10.73 | 140 / 183 |
breast | 36% | 272.35 | 167 / 459 | 92% | 20.17 | 1028 / 1118 |
adrenal gland | 32% | 310.05 | 83 / 258 | 85% | 49.39 | 196 / 230 |
uterus | 72% | 691.58 | 123 / 170 | 43% | 8.73 | 198 / 459 |
lung | 47% | 380.91 | 273 / 578 | 58% | 7.72 | 667 / 1155 |
stomach | 33% | 471.20 | 119 / 359 | 71% | 7.76 | 203 / 286 |
bladder | 48% | 596.33 | 10 / 21 | 55% | 7.40 | 278 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.83 | 1 / 1 |
thymus | 6% | 33.19 | 41 / 653 | 86% | 21.86 | 523 / 605 |
pancreas | 3% | 17.15 | 10 / 328 | 85% | 8.50 | 152 / 178 |
muscle | 82% | 985.13 | 658 / 803 | 0% | 0 | 0 / 0 |
kidney | 13% | 75.35 | 12 / 89 | 65% | 9.85 | 586 / 901 |
eye | 0% | 0 | 0 / 0 | 75% | 7.69 | 60 / 80 |
skin | 10% | 62.15 | 182 / 1809 | 47% | 6.63 | 223 / 472 |
blood vessel | 51% | 694.69 | 677 / 1335 | 0% | 0 | 0 / 0 |
heart | 48% | 402.05 | 413 / 861 | 0% | 0 | 0 / 0 |
ovary | 8% | 66.66 | 14 / 180 | 40% | 3.06 | 171 / 430 |
tonsil | 0% | 0 | 0 / 0 | 47% | 9.06 | 21 / 45 |
adipose | 18% | 122.67 | 221 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 11% | 0.58 | 45 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0001963 | Biological process | synaptic transmission, dopaminergic |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0033235 | Biological process | positive regulation of protein sumoylation |
GO_0043949 | Biological process | regulation of cAMP-mediated signaling |
GO_0007626 | Biological process | locomotory behavior |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005525 | Molecular function | GTP binding |
GO_0031681 | Molecular function | G-protein beta-subunit binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RASD2 |
Protein name | GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) |
Synonyms | TEM2 |
Description | FUNCTION: GTPase signaling protein that binds to and hydrolyzes GTP. Regulates signaling pathways involving G-proteins-coupled receptor and heterotrimeric proteins such as GNB1, GNB2 and GNB3. May be involved in selected striatal competencies, mainly locomotor activity and motor coordination. . |
Accessions | ENST00000216127.5 Q96D21 |